Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001078782-18-000285
Filing Date
2018-03-08
Accepted
2018-03-08 16:06:02
Documents
7

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROSPECTUS SUPPLEMENT 424b5030718_424b5.htm 424B5 342288
2 IMAGE f424b5030718_424b51.jpg GRAPHIC 247477
3 IMAGE f424b5030718_424b52.jpg GRAPHIC 2330
4 IMAGE f424b5030718_424b53.jpg GRAPHIC 63881
5 IMAGE f424b5030718_424b54.jpg GRAPHIC 116779
6 IMAGE f424b5030718_424b55.jpg GRAPHIC 8055
7 IMAGE f424b5030718_424b56.jpg GRAPHIC 2330
  Complete submission text file 0001078782-18-000285.txt   951015
Mailing Address 1 SCOTTS RD #24-05 SHAW CENTRE SINGAPORE U0 228208
Business Address 1 SCOTTS RD #24-05 SHAW CENTRE SINGAPORE U0 228208 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-206781 | Film No.: 18676484
SIC: 2835 In Vitro & In Vivo Diagnostic Substances